To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C1orf124TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
199 supporting clones for gene C1orf124 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_032018.4   .a 1 to 2799 1 to 2799 exact RefSeq, AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 2799/2799
(100 %)
0 diff
(100 %id)
BC068478 testis .a 50 to 2797 1 to 2748 P296L tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 2748/2750
(99 %)
3 diff
(99.9 %id)
AK027613   .a 321 to 2791 1 to 2470 P296L available from FLJ,   2470/2470
(100 %)
3 diff
(99.9 %id)
DA735289   .a 322 to 1186 2 to 864   capped   863/863
(100 %)
5 diff
(99.5 %id)
AL583485 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 344 to 1199 1 to 854       854/854
(100 %)
2 diff
(99.8 %id)
AA081452   .a 372 to 684 1 to 315       315/315
(100 %)
5 diff
(98.5 %id)
AL512744 brain .a 387 to 2799 1 to 2413 P296L tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 2413/2413
(100 %)
2 diff
(100.0 %id)
TI_159694582   .a 676 to 1311 729 to 95   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 635/1077
(58 %)
24 diff
(97.8 %id)
AW341460 pooled .a 761 to 1311 552 to 2       551/552
(99 %)
3 diff
(99.5 %id)
AA084733   .a 918 to 1306 395 to 1       395/397
(99 %)
11 diff
(97.3 %id)
CF272299 Brain glioblastoma .a 950 to 1415 1 to 466       466/688
(67 %)
2 diff
(99.8 %id)
CN298868 embryonic stem cells, cell lines H1, H7, andH9 .a 1038 to 1723 24 to 709       686/709
(96 %)
7 diff
(99.1 %id)
BE018066 cervical carcinoma cell line, cervix .a 1049 to 1555 1 to 507     Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 507/507
(100 %)
1 diff
(99.9 %id)
CN298866 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1133 to 1672 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
AL521107 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 2223 to 2448 225 to 1       644/911
(70 %)
71 diff
(92.3 %id)
DB367526   .a 2239 to 2791 551 to 1       551/551
(100 %)
2 diff
(99.7 %id)
BE301472 cervical carcinoma cell line, cervix .a 2334 to 2799 478 to 13   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 466/466
(100 %)
0 diff
(100 %id)
CA428299 Bone, Subchondral Bone .b 1 to 662 674 to 15   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 660/674
(97 %)
3 diff
(99.6 %id)
BM794141 Ascites, stomach .b 151 to 792 1 to 642       642/642
(100 %)
1 diff
(99.9 %id)
DB268683 uterus .b 151 to 690 2 to 541   tiling clone, capped   540/540
(100 %)
1 diff
(99.9 %id)
AW386826 pnet .b 168 to 693 528 to 5       524/532
(98 %)
6 diff
(98.9 %id)
AW581647 pnet .b 185 to 642 461 to 1       461/461
(100 %)
18 diff
(96.1 %id)
BM127014 Islets of Langerhans, Pancreas .b 203 to 654 1 to 452   fully sequenced,   452/452
(100 %)
0 diff
(100 %id)
AA579673 colon, colon tumor RER+ .b 217 to 746 531 to 2       530/531
(99 %)
9 diff
(98.4 %id)
BM126719 Islets of Langerhans, Pancreas .b 624 to 1040 417 to 1   tiling clone, fully sequenced,   417/417
(100 %)
2 diff
(99.6 %id)
BF571132 melanotic melanoma, high MDR, skin .b 1634 to 2334 1 to 708       708/796
(88 %)
61 diff
(92.4 %id)
BF978051 melanotic melanoma, high MDR, skin .b 1634 to 2311 1 to 670   tiling clone,   670/698
(95 %)
14 diff
(98.0 %id)
BF977689 melanotic melanoma, high MDR, skin .b 1634 to 2257 1 to 625       625/625
(100 %)
9 diff
(98.6 %id)
BQ695202 adipose .b 1901 to 2414 1 to 514   tiling clone,   514/514
(100 %)
7 diff
(98.7 %id)
BF572178 melanotic melanoma, high MDR, skin .b 2273 to 2371 662 to 759   tiling clone,   630/829
(75 %)
32 diff
(96.2 %id)
CD359590 testis .c 1 to 734 21 to 756   tiling clone,   736/906
(81 %)
21 diff
(97.7 %id)
FN177428 breast carcinoma .c 733 to 818 1 to 87   tiling clone,   87/87
(100 %)
5 diff
(94.3 %id)
CN298865 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 793 to 1466 1 to 676   tiling clone,   676/676
(100 %)
5 diff
(99.3 %id)
BM480135 duodenal adenocarcinoma, cell line, small intestine .c 1002 to 1754 13 to 768   tiling clone,   756/1042
(72 %)
26 diff
(97.6 %id)
F08484 brain, total brain .c 1040 to 1337 1 to 298       298/298
(100 %)
5 diff
(98.4 %id)
F06518 brain, total brain .c 1045 to 1372 6 to 333       328/333
(98 %)
6 diff
(98.2 %id)
Z43401 brain, total brain .c 1052 to 1415 14 to 377       364/379
(96 %)
3 diff
(99.3 %id)
F05301 brain, total brain .c 1053 to 1310 1 to 258       258/258
(100 %)
1 diff
(99.7 %id)
R25827 whole brain .c 1053 to 1432 1 to 394     Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 394/396
(99 %)
31 diff
(92.2 %id)
BG572915 placenta .c 1102 to 1799 1 to 696       696/696
(100 %)
2 diff
(99.8 %id)
AI024732   .c 1263 to 1747 487 to 3       485/487
(99 %)
0 diff
(100 %id)
AI863537 Kidney .c 1347 to 1737 392 to 1       392/392
(100 %)
3 diff
(99.3 %id)
EC579846 Prostate .c 1403 to 1506 110 to 5       106/110
(96 %)
0 diff
(100 %id)
AW978863   .c 1544 to 2283 741 to 1     Submitted on the opposite strand 741/741
(100 %)
6 diff
(99.2 %id)
CN298869 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1570 to 1896 1 to 328       328/328
(100 %)
2 diff
(99.4 %id)
BX106387 whole brain .c 1639 to 2279 655 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 641/641
(100 %)
0 diff
(100 %id)
BE856968 pooled .c 1718 to 2279 576 to 15   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 562/562
(100 %)
3 diff
(99.5 %id)
CN298867 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1734 to 2275 1 to 542       542/542
(100 %)
0 diff
(100 %id)
BF571162 melanotic melanoma, high MDR, skin .c 1763 to 2419 1 to 662       662/742
(89 %)
55 diff
(92.6 %id)
CB142597 Liver .c 1765 to 2220 1 to 456       456/456
(100 %)
0 diff
(100 %id)
CN298870 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1826 to 2182 1 to 357       357/357
(100 %)
3 diff
(99.2 %id)
DB525568 testis .c 1834 to 2277 1 to 444     Submitted on the opposite strand 444/446
(99 %)
1 diff
(99.8 %id)
AA829880 germinal center B cell .c 1835 to 2290 459 to 4       456/459
(99 %)
0 diff
(100 %id)
DB511648 testis .c 1926 to 2279 12 to 365     Submitted on the opposite strand 354/365
(96 %)
6 diff
(98.4 %id)
R46825 whole brain .c 1951 to 2279 355 to 18   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 338/338
(100 %)
14 diff
(95.9 %id)
BF509960   .c 1986 to 2279 311 to 18   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 294/304
(96 %)
0 diff
(100 %id)
Z39470 brain, total brain .c 2003 to 2279 277 to 1       277/277
(100 %)
0 diff
(100 %id)
F04699 brain, total brain .c 2044 to 2279 236 to 1       236/236
(100 %)
0 diff
(100 %id)
AA757970   .c 2056 to 2279 236 to 13   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 224/224
(100 %)
0 diff
(100 %id)
F02793 brain, total brain .c 2073 to 2279 207 to 1       207/207
(100 %)
0 diff
(100 %id)
F01559 brain, total brain .c 2074 to 2279 206 to 1       206/206
(100 %)
0 diff
(100 %id)
BQ962863 leiomyosarcoma, uterus .c 2152 to 2984 1 to 849   tiling clone,   849/905
(93 %)
15 diff
(98.4 %id)
TI_149304690   .c 2180 to 3058 952 to 86   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 867/971
(89 %)
21 diff
(97.9 %id)
DB517609 testis .c 2301 to 2749 1 to 449     Submitted on the opposite strand 449/449
(100 %)
1 diff
(99.8 %id)
BM971303 lung .c 2311 to 3058 767 to 19   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 749/749
(100 %)
3 diff
(99.6 %id)
BU630543 cell lines, Chondrosarcoma .c 2335 to 3062 746 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 728/728
(100 %)
3 diff
(99.6 %id)
AA586969 larynx .c 2338 to 2751 414 to 2       413/414
(99 %)
0 diff
(100 %id)
AW137981   .c 2338 to 2751 427 to 16   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 412/412
(100 %)
4 diff
(99.1 %id)
TI_154020487   .c 2365 to 3059 783 to 89   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 695/713
(97 %)
2 diff
(99.8 %id)
CA438464 lung, Metastatic Chondrosarcoma .c 2368 to 3059 710 to 19   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 692/692
(100 %)
2 diff
(99.8 %id)
FN046444 breast carcinoma .c 2371 to 2479 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
AI952663 normal epithelium, ovary .c 2464 to 2749 308 to 23   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 286/286
(100 %)
0 diff
(100 %id)
AI425019 pooled .c 2559 to 3066 509 to 2       508/509
(99 %)
0 diff
(100 %id)
DB528236 testis .c 2567 to 3048 1 to 482     Submitted on the opposite strand 482/483
(99 %)
1 diff
(99.8 %id)
BE176230 head_neck .c 2603 to 2840 1 to 237       237/254
(93 %)
6 diff
(97.7 %id)
AI860772 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2612 to 3059 459 to 12   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 448/448
(100 %)
0 diff
(100 %id)
AA825746 germinal center B cell .c 2624 to 3066 445 to 3       443/445
(99 %)
0 diff
(100 %id)
DB525127 testis .c 2625 to 3056 1 to 432     Submitted on the opposite strand 432/434
(99 %)
2 diff
(99.6 %id)
DB512776 testis .c 2632 to 3058 1 to 430     Submitted on the opposite strand 430/430
(100 %)
4 diff
(99.1 %id)
AA952985 pooled .c 2695 to 3059 365 to 1       365/365
(100 %)
0 diff
(100 %id)
AW072076 pooled .c 2715 to 3060 351 to 6       346/351
(98 %)
0 diff
(100 %id)
AI250178 adenocarcinoma, Pancreas .c 2767 to 3059 313 to 21   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 293/293
(100 %)
0 diff
(100 %id)
AY358611   .d 1 to 3559 1 to 3560 exact tiling clone,   3560/3567
(99 %)
3 diff
(100.0 %id)
BG718257 testis .d 827 to 1587 1 to 765       765/765
(100 %)
19 diff
(97.6 %id)
NM_001010984.1   .d 833 to 4669 1 to 3837 exact RefSeq, AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 3837/3837
(100 %)
0 diff
(100 %id)
DB062812 testis .d 862 to 1395 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
BI562504 testis .d 877 to 1512 1 to 651       651/670
(97 %)
21 diff
(96.9 %id)
DB241048 trachea .d 878 to 1450 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
TI_44350494   .d 882 to 1512 122 to 767       646/786
(82 %)
19 diff
(97.6 %id)
DN993057 brain, whole brain .d 902 to 1526 15 to 638       624/638
(97 %)
5 diff
(99.3 %id)
DB459686 testis .d 904 to 1339 1 to 436       436/436
(100 %)
2 diff
(99.6 %id)
DA453999 tongue, tumor tissue .d 906 to 1469 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB035244 testis .d 921 to 1465 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BG704879 brain, hippocampus .d 940 to 1603 1 to 665       665/665
(100 %)
6 diff
(99.1 %id)
BM146501 leukopheresis .d 940 to 1329 1 to 390       390/391
(99 %)
7 diff
(98.3 %id)
DA403931 thalamus .d 941 to 1495 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BQ073042 leukocyte .d 942 to 1706 1 to 772       772/1076
(71 %)
24 diff
(97.8 %id)
DA372697 thalamus .d 944 to 1490 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BG746792 adenocarcinoma cell line, colon .d 944 to 1864 1 to 920       920/920
(100 %)
23 diff
(97.5 %id)
BG823699 adenocarcinoma cell line, colon .d 944 to 1647 1 to 709   available from MGC,   709/709
(100 %)
17 diff
(97.7 %id)
DA946016 Spleen .d 944 to 1509 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA397123 thalamus .d 945 to 1525 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BC015740 Colon, adenocarcinoma .d 945 to 2011 1 to 1067   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1067/1087
(98 %)
1 diff
(100.0 %id)
DB446464 testis .d 946 to 1392 1 to 448       448/448
(100 %)
5 diff
(98.9 %id)
DA459380 tongue, tumor tissue .d 947 to 1472 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA489768 brain .d 947 to 1472 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA657326   .d 947 to 1505 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB232753 trachea .d 947 to 1488 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB057352 testis .d 948 to 1432 2 to 486   capped   485/485
(100 %)
1 diff
(99.8 %id)
DT217626 brain .d 953 to 1577 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
DA414171 thalamus .d 954 to 1513 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CB123843 Liver .d 956 to 1388 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
DA823503 pericardium .d 957 to 1506 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BM825143 Ascites, stomach .d 962 to 1457 1 to 496       496/496
(100 %)
0 diff
(100 %id)
R11413 liver and spleen .d 971 to 1267 1 to 298       298/434
(68 %)
7 diff
(98.4 %id)
BG721494 testis .d 1161 to 2075 1 to 775       775/776
(99 %)
13 diff
(98.4 %id)
BG721564 testis .d 1161 to 1868 1 to 707       707/707
(100 %)
6 diff
(99.2 %id)
DA531312 brain .d 1164 to 1753 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DB447693 testis .d 1164 to 1601 1 to 439       439/449
(97 %)
5 diff
(98.9 %id)
DB462766 testis .d 1164 to 1654 1 to 491       491/491
(100 %)
3 diff
(99.4 %id)
TI_57149252   .d 1164 to 1927 33 to 798       766/798
(95 %)
8 diff
(99.0 %id)
BI761715 pooled colon, kidney, stomach .d 1165 to 1927 1 to 765       765/765
(100 %)
2 diff
(99.8 %id)
DA376824 thalamus .d 1168 to 1730 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DB143744 thymus .d 1168 to 1700 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB165768 thymus .d 1168 to 1761 2 to 597   capped   596/596
(100 %)
3 diff
(99.5 %id)
DA750544   .d 1177 to 1763 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DB212806 trachea .d 1177 to 1443 2 to 268   capped   267/267
(100 %)
0 diff
(100 %id)
DA358059 subthalamic nucleus .d 1187 to 1760 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
BI761536 pooled colon, kidney, stomach .d 1187 to 1953 1 to 769       769/769
(100 %)
5 diff
(99.4 %id)
TI_57149341   .d 1187 to 1953 31 to 799       769/799
(96 %)
11 diff
(98.7 %id)
CB994778 placenta, pre-eclamptic placenta .d 1190 to 1924 28 to 768       741/771
(96 %)
15 diff
(98.1 %id)
CD109861 Human Placenta, placenta .d 1190 to 1962 28 to 813   AAA   786/848
(92 %)
32 diff
(96.3 %id)
CF594074 Human Placenta, placenta .d 1190 to 1981 29 to 825       797/866
(92 %)
13 diff
(98.5 %id)
DA027619   .d 1191 to 1762 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA036543 breast .d 1191 to 1755 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA067871 cerebellum .d 1191 to 1763 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA455318 tongue, tumor tissue .d 1191 to 1760 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA455920 tongue, tumor tissue .d 1191 to 1762 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA607730   .d 1191 to 1815 2 to 627   capped   626/626
(100 %)
2 diff
(99.7 %id)
DA618464   .d 1191 to 1760 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA660688   .d 1191 to 1754 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
DA665791   .d 1191 to 1737 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA712339   .d 1191 to 1731 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DA882242   .d 1191 to 1736 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA953887 Spleen .d 1191 to 1751 2 to 566   capped   565/565
(100 %)
7 diff
(98.8 %id)
DB078412 testis .d 1191 to 1763 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB079303 testis .d 1191 to 1758 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DB082606 testis .d 1191 to 1755 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB100180 testis .d 1191 to 1773 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB258958 uterus .d 1191 to 1764 2 to 575   capped   574/575
(99 %)
1 diff
(99.9 %id)
BI459193 testis .d 1192 to 1822 1 to 633       633/637
(99 %)
9 diff
(98.6 %id)
DB079967 testis .d 1192 to 1606 2 to 416   capped   415/415
(100 %)
1 diff
(99.8 %id)
DB080032 testis .d 1192 to 1769 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
BG718264 testis .d 1198 to 1992 1 to 796       796/800
(99 %)
9 diff
(98.9 %id)
BX356479.
matches multiple genes
Placenta Cot 25-normalized .d 1203 to 1998 1 to 798     also hits gene TAF1A 798/874
(91 %)
8 diff
(99.1 %id)
BE410227 choriocarcinoma, placenta .d 1204 to 1722 54 to 571       518/571
(90 %)
6 diff
(99.0 %id)
BG721688 testis .d 1205 to 1867 1 to 663       663/663
(100 %)
3 diff
(99.6 %id)
DB460129 testis .d 1206 to 1665 1 to 460       460/460
(100 %)
1 diff
(99.8 %id)
AA360189   .d 1251 to 1469 1 to 218       218/218
(100 %)
3 diff
(98.7 %id)
AW404616 lymph .d 1260 to 1735 1 to 476       476/483
(98 %)
8 diff
(98.4 %id)
TI_154141632   .d 1266 to 2010 79 to 814       736/764
(96 %)
33 diff
(95.7 %id)
CV030145 mixed .d 1281 to 1738 1 to 459       459/459
(100 %)
2 diff
(99.6 %id)
EL736838 mixed .d 1281 to 1871 1 to 591       591/591
(100 %)
0 diff
(100 %id)
TI_1948100998   .d 1281 to 2004 129 to 858   fully sequenced,   730/858
(85 %)
18 diff
(98.0 %id)
TI_1948101145   .d 1281 to 1532 132 to 383   fully sequenced,   252/280
(90 %)
6 diff
(97.9 %id)
TI_1948101292   .d 1281 to 1833 134 to 686       553/1403
(39 %)
31 diff
(97.8 %id)
TI_1948101427   .d 1281 to 1842 129 to 699   fully sequenced,   571/699
(81 %)
18 diff
(97.5 %id)
CA432649 cell lines, Chondrosarcoma .d 1282 to 2004 746 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 748/746
(100 %)
58 diff
(92.3 %id)
BG036149 adenocarcinoma, cell line, Liver .d 1292 to 2001 1 to 709       709/979
(72 %)
20 diff
(98.0 %id)
CV573663 cornea, eye .d 1394 to 1896 1 to 503       503/503
(100 %)
8 diff
(98.5 %id)
AI984687 colon, colonic mucosa from 3 patients with Crohn'sdisease .d 1485 to 1943 462 to 4   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 459/462
(99 %)
1 diff
(99.8 %id)
TI_1948101146   .d 1502 to 2004 637 to 123   fully sequenced,   527/649
(81 %)
56 diff
(91.4 %id)
CA307905 Alveolar Macrophage, lung .d 1619 to 2387 786 to 19   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 768/768
(100 %)
5 diff
(99.4 %id)
BU622255 Cell Line, Chondrosarcoma .d 1677 to 2387 729 to 19   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 711/723
(98 %)
3 diff
(99.6 %id)
BI038800 nervous_tumor .d 1735 to 1894 170 to 12       159/170
(93 %)
0 diff
(100 %id)
TI_1948100999   .d 1797 to 2014 337 to 120   fully sequenced,   218/337
(64 %)
3 diff
(99.2 %id)
TI_1948101428   .d 1812 to 2016 323 to 119   fully sequenced,   205/227
(90 %)
5 diff
(97.8 %id)
AI659669 Prostate .d 2423 to 2959 537 to 1       537/537
(100 %)
1 diff
(99.9 %id)
AK027317 whole embryo, mainly head .e 1 to 1656 3 to 1659 G179R K180Q G181R A183G L185T ... tiling clone, available from FLJ,   1659/1659
(100 %)
2 diff
(99.9 %id)
DA570307 whole embryo, mainly head .e 1 to 774 3 to 776 G179R K180Q G181R A183G L185T ... capped   775/778
(99 %)
8 diff
(99.0 %id)
DN994400 brain, whole brain .e 11 to 588 1 to 578       578/578
(100 %)
5 diff
(99.2 %id)
DB073330 testis .e 14 to 544 2 to 534   capped   533/533
(100 %)
3 diff
(99.5 %id)
DB357066 whole embryo, mainly head .e 1079 to 1656 573 to 1       573/576
(99 %)
12 diff
(98.0 %id)
DB452080 testis .f 1 to 500 1 to 500 exact tiling clone,   500/500
(100 %)
1 diff
(99.8 %id)
T87282 liver and spleen .g 65 to 397 1 to 340   tiling clone,   340/342
(99 %)
19 diff
(94.5 %id)
CB994504 placenta, pre-eclamptic placenta .g 285 to 889 28 to 635 exact tiling clone,   608/859
(70 %)
12 diff
(98.7 %id)
CB994673 placenta, pre-eclamptic placenta .g 285 to 874 28 to 621 exact AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 594/621
(95 %)
10 diff
(98.4 %id)
CB994332 placenta, pre-eclamptic placenta .g 285 to 860 28 to 608 K67E AAA   581/861
(67 %)
13 diff
(98.5 %id)
AA693492   .g 405 to 864 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
W15342 parathyroid gland, parathyroid tumor .g 520 to 875 361 to 1       361/391
(92 %)
6 diff
(98.5 %id)
T87195 liver and spleen .g 548 to 881 340 to 1   tiling clone,   337/414
(81 %)
17 diff
(95.9 %id)
AI284434 lymph node, mantle cell lymphoma .h 1 to 365 365 to 1   tiling clone,   365/365
(100 %)
5 diff
(98.7 %id)
FN166030 breast carcinoma .h 104 to 226 123 to 1     Submitted on the opposite strand 123/123
(100 %)
3 diff
(97.6 %id)
FN169069 breast carcinoma .h 104 to 226 122 to 1     Submitted on the opposite strand 122/122
(100 %)
4 diff
(96.8 %id)
BX090110 liver and spleen .h 167 to 664 1 to 496   tiling clone, AAA   496/496
(100 %)
4 diff
(99.2 %id)
AI022301 liver and spleen .h 385 to 664 280 to 1       280/280
(100 %)
3 diff
(99.0 %id)
AW340107 pooled .h 637 to 1031 398 to 4   tiling clone,   395/398
(99 %)
0 diff
(100 %id)
DA655703   .i 1 to 563 2 to 564 exact tiling clone, capped   563/563
(100 %)
0 diff
(100 %id)
CF137435 lymph .i 456 to 913 8 to 465   tiling clone,   458/465
(98 %)
6 diff
(98.8 %id)
TI_154166853   .i 456 to 995 80 to 619   tiling clone,   540/540
(100 %)
1 diff
(99.9 %id)
AW614332 Kidney .j-u 1 to 464 464 to 1 exact tiling clone,   464/464
(100 %)
1 diff
(99.8 %id)
BM929404 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k-u 1 to 379 1 to 380 K13E R14E H15T G16W I17D ... tiling clone,   380/427
(88 %)
6 diff
(98.6 %id)
AL601965   .k-u 45 to 430 386 to 1   tiling clone, Submitted on the opposite strand 386/386
(100 %)
0 diff
(100 %id)
BG189008   .k-u 98 to 387 1 to 289   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 289/289
(100 %)
17 diff
(94.2 %id)
BG189571   .k-u 99 to 397 1 to 300   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 300/300
(100 %)
13 diff
(95.7 %id)
BG198729   .k-u 105 to 391 14 to 300   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 287/300
(95 %)
11 diff
(96.4 %id)
BG203870   .k-u 110 to 391 1 to 281   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 281/281
(100 %)
5 diff
(98.3 %id)
CN298871 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l-u 1 to 332 8 to 339 exact tiling clone,   332/339
(97 %)
6 diff
(98.3 %id)
AV681850 hepatocellular carcinoma Gene C1orf124, variant not shown         Suspected internal deletion, this clone was ignored    
AV727888 hypothalamus Gene C1orf124, variant not shown         Suspected internal deletion, this clone was ignored    
CB044867 colon, juvenile granulosa tumor Gene C1orf124, variant not shown       AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base)    
CB044868 colon, juvenile granulosa tumor Gene C1orf124, variant not shown         Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base)    
BI559883 testis Gene C1orf124, variant not shown         This clone was ignored    
BU597082 mixed (pool of 40 RNAs) Gene C1orf124, variant not shown         This clone was ignored    
TI_44348363   Gene C1orf124, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k-u, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI